RankAlpha logo
Back to Rankings

INAB

IN8bioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
INAB vs peer average
46/100
INAB vs. peer average (D vs. D)
Grade spread
A 2 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

JSPR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $15.44M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerJSPRJasper Therapeutics
INAB
IN8bio
JSPR
Jasper Therapeutics
Grade
D
A
Momentum
42
61
Value
41
58
Sentiment
-
68
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs JSPR

INAB / JSPR
Grade Position
In line
INAB vs. peer average (D vs. D)
46/100
Momentum
42
JSPR
Value
41
JSPR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs INAB
1
JSPR
Jasper Therapeutics Inc Common
A
100/100
-3
2
LEXX
Lexaria Bioscience Corp Common
D
40/100
Even
3
BLRX
BioLineRX Ltd ADR
F
20/100
+1
4
HIND
Vyome Holdings Inc Common
F
20/100
+1
5
COCP
Cocrystal Pharma Inc Common
A
100/100
-3
JSPR is the first peer returned for this comparison set.